Ignite Creation Date:
2025-12-24 @ 5:08 PM
Ignite Modification Date:
2026-01-01 @ 8:31 AM
Study NCT ID:
NCT05243550
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-11-04
First Post:
2022-02-07
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 3 Single-Arm Study of UGN-102 for Treatment of Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
Sponsor:
UroGen Pharma Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
BL011
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None